Due to the pandemic, the District Court entered an Order today cancelling all criminal and civil jury trials in the United States District Court for the District of Delaware until
Continue Reading Court Enters Order Cancelling Civil and Criminal Jury Trials in the District of Delaware Until On or After April 5, 2021 Due to COVID-19 Pandemic
Antitrust and Patent Misuse
Happy New Year!
Wishing all followers of the Delaware Intellectual Property Litigation Blog a Happy, Prosperous and Safe 2021!
Gregory B. Williams, Fox Rothschild LLP
Merry Christmas!
Have a Merry Christmas! Stay Safe.
Continue Reading Merry Christmas!
HAPPY THANKSGIVING!
Have a Happy Thanksgiving! Stay Safe.
Continue Reading HAPPY THANKSGIVING!
Judge Andrews Denies Without Prejudice Plaintiff’s Daubert Motion to Exclude Testimony of Defendant’s Experts in Support of Patent Misuse Defense
By Memorandum Order entered by The Honorable Richard G. Andrews in Ingevity Corp. et al. v. BASF Corp., Civil Action No. 18-1391-RGA (D.Del. October 21, 2020), the Court denied…
Continue Reading Judge Andrews Denies Without Prejudice Plaintiff’s Daubert Motion to Exclude Testimony of Defendant’s Experts in Support of Patent Misuse Defense
District of Delaware Announces Plan to Transition to Phase 2 of the District’s Re-Opening Guidelines on September 15, 2020
By Standing Order entered by Chief District Judge Leonard P. Stark on September 1, 2020, the United States District Court for the District of Delaware announced its plan to transition…
Continue Reading District of Delaware Announces Plan to Transition to Phase 2 of the District’s Re-Opening Guidelines on September 15, 2020
Following ANDA Trial, Chief Judge Stark Finds Remaining Defendants’ Proposed Drug Products Infringe Asserted Claims of Patents-in-Suit Connected to Plaintiffs’ Eliquis® Product
By Opinion entered by The Honorable Leonard P. Stark in Bristol-Myers Squibb Co. et al v. Aurobindo Pharma USA Inc. et al., Civil Action No. 17-374-LPS (D.Del. August 5,…
Continue Reading Following ANDA Trial, Chief Judge Stark Finds Remaining Defendants’ Proposed Drug Products Infringe Asserted Claims of Patents-in-Suit Connected to Plaintiffs’ Eliquis® Product
Civil and Criminal Jury Trials in the District of Delaware Will Not Resume Until At Least August 31, 2020 due to COVID-19
Due to public safety concerns caused by COVID-19, by Standing Order entered by Chief Judge Leonard P. Stark dated July 16, 2020, the United States District Court for the District…
Continue Reading Civil and Criminal Jury Trials in the District of Delaware Will Not Resume Until At Least August 31, 2020 due to COVID-19
Business Litigation in Delaware State Courts
Although I typically blog on intellectual property and antitrust cases in federal court in Delaware, attached for readers of the Delaware Intellectual Property Litigation Blog are links to two articles …
Continue Reading Business Litigation in Delaware State Courts
District of Delaware Adopts Re-Opening Guidelines and Will Commence Phase One Operations on June 17, 2020
By Order dated June 15, 2020 and issued by Chief Judge Stark, the United States District Court for the District of Delaware issued and adopted its re-opening guidelines that includes…
Continue Reading District of Delaware Adopts Re-Opening Guidelines and Will Commence Phase One Operations on June 17, 2020